OncoIndustry
Mohit Manrao on the Next Era of Cell Therapy
Mohit Manrao/LinkedIn

Mohit Manrao on the Next Era of Cell Therapy

Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn:

“Cell therapy is reshaping how we think about the future of cancer care.

At AstraZeneca, we’re exploring ways to make these therapies more effective, scalable and accessible so they can reach more people living with cancer.

Our latest ‘What Science Can Do’ article looks at progress across blood cancers and the challenges researchers are working to address in hard-to-treat solid tumours.

Three areas of focus include:

  • Expanding cell therapy beyond established blood-cancer applications
  • Reducing manufacturing times and treatment burden
  • Developing new technologies for solid tumours

Read the full article.”

Mohit Manrao on the Next Era of Cell Therapy

Other articles about AstraZeneca on OncoDaily.

adoptive cell therapy advanced cell therapy AstraZeneca blood cancers cancer Cancer Cell Therapy cancer immunotherapy Cancer research cancer treatment cancer treatment innovation CAR T-cell therapy CAR T-Cell Therapy Research Cell Therapy cell therapy manufacturing cell therapy research Cellular Therapy hematologic malignancies immunotherapy Mohit Manrao OncoDaily Oncology oncology research solid tumors Solid Tumour Oncology T-cell therapy What Science Can Do